Vallon Pharmaceuticals
Why Robinhood?
You can watch VLON and buy or sell other stocks, ETFs, and their options commission-free!About VLON
GRI Bio, Inc. engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis.
VLON Key Statistics
Stock Snapshot
With a market cap of 12.13M, Vallon Pharmaceuticals(VLON) trades at $5.55. The stock has a price-to-earnings ratio of -0.03.
On 2026-10-23, Vallon Pharmaceuticals(VLON) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Vallon Pharmaceuticals(VLON) stock has reached 0, versus its average volume of 50.33K.
The stock's 52-week range extends from a low of $1.36 to a high of $64.12.
The stock's 52-week range extends from a low of $1.36 to a high of $64.12.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.